46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details

臨床試験数 : 4,325 / 薬物数 : 2,671 - (DrugBank : 417) / 標的遺伝子数 : 187 - 標的パスウェイ数 : 224

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01236118 (ClinicalTrials.gov)	December 2010	4/11/2010	A Study of LY2439821 in Rheumatoid Arthritis	An Open-Label Extension Study to Evaluate Safety and Tolerability of Multiple Subcutaneous Doses of ...	Rheumatoid Arthritis	Drug: LY2439821	Eli Lilly and Company	NULL	Completed	20 Years	N/A	All	28	Phase 1	Japan
2	NCT01253265 (ClinicalTrials.gov)	May 2010	1/12/2010	A Study in Rheumatoid Arthritis	Multiple-Dose, Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmaco ...	Rheumatoid Arthritis	Drug: LY2439821;Drug: Placebo	Eli Lilly and Company	NULL	Completed	20 Years	75 Years	All	32	Phase 1	Japan
3	EUCTR2009-009696-34-DE (EUCTR)	23/11/2009	14/05/2009	A Study in Patients with Rheumatoid Arthritis	A Phase 2 Dose-Ranging Study of Multiple Subcutaneous Doses of LY2439821(an Anti-IL-17 Antibody) in ...	Rheumatoid Arthritis MedDRA version: 14.0;Level: PT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: LY2439821 Product Code: LY2439821 INN or Proposed INN: N.A.	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	648	Phase 2	India;Russian Federation;Germany;Peru;Taiwan;Argentina;Romania;Korea, Republic of;Chile;Poland
4	NCT00966875 (ClinicalTrials.gov)	August 2009	25/8/2009	A Study in Patients With Rheumatoid Arthritis	A Phase 2 Dose-Ranging Study of Multiple Subcutaneous Doses of LY2439821(an Anti-IL-17 Antibody) in ...	Rheumatoid Arthritis	Biological: LY2439821;Drug: Placebo	Eli Lilly and Company	NULL	Completed	18 Years	75 Years	All	448	Phase 2	United States;Argentina;Chile;Germany;India;Korea, Republic of;Peru;Poland;Romania;Russian Federatio ...

First Previous1Next Last